If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that mimics epinephrine and can bind to the epinephrine receptor.
B) that stimulates cAMP production in liver cells.
C) to stimulate G protein activity in liver cells.
D) that increases phosphodiesterase activity.
E) that does any of the above.
Answer: D
If the answers is incorrect or not given, you can answer the above question in the comment box. If the answers is incorrect or not given, you can answer the above question in the comment box.